Andrea Stringer

Associate Professor Andrea Stringer is affiliated with the University of South Australia's Clinical & Health Sciences school, holding an Associate Professor position in Medical Sciences. She is actively involved in research degree supervision and available for media inquiries. Her work focuses on gastrointestinal toxicity and mucositis pathogenesis in cancer therapies, emphasizing microbiome interactions and drug delivery innovations.

Research interests include chemotherapy-induced mucositis mechanisms, microbiome's role in drug efficacy, radiation therapy side effects, and translational strategies for clinical applications. Over 50 peer-reviewed articles span from 2006 to 2025, highlighting contributions to animal models, clinical guidelines (e.g., MASCC/ISOO frameworks), and biomarker discovery in gastrointestinal toxicity.

Key areas of investigation involve the gut microbiome's impact on drug pharmacokinetics, vitamin D's therapeutic potential for mucosal healing, and novel drug delivery systems to mitigate toxicities. Her studies often utilize rodent models to explore molecular pathways and systemic inflammatory responses linked to anticancer treatments.

Publications consistently emphasize methodological rigor in microbiome research and translational outcomes, with recent work addressing challenges in conducting robust microbiome science and optimizing fecal microbiota transplantation protocols.